The global Menstrual Cramps Treatment Market is estimated to be valued at US$ 652.3 Mn or in 2023 and is expected to exhibit a CAGR of 4.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Menstrual cramps treatment products are used to reduce pain caused during menstruation. Common menstrual cramps treatment products include pain medications, heating pads, menstrual cups, menstrual underwear, and other devices. Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and naproxen are among the most widely used over-the-counter pain medications to treat menstrual cramps. Heating pads provide temporary relief by increasing blood flow when applied to the lower abdomen or back area. Menstrual cups and menstrual underwear are alternatives to traditional pads and tampons, which can help reduce bloating and discomfort associated with menstrual cramps.
Market key trends:
Growing awareness regarding various treatment options for managing menstrual pain is expected to drive the Menstrual Cramps Treatment Market growth over the forecast period. Rising investment in research and development of innovative menstrual products such as reusable silicone menstrual cups and herbal supplements is another key trend in the market. In addition, increasing preference for organic and natural period care products due to rising health concerns regarding chemical-based pain medications is fueling demand in the market.
Porter's Analysis
Threat of new entrants: The threat of new entrants in the menstrual cramps treatment market is moderate. High capital requirements for Research and Development pose a barrier for new companies.
Bargaining power of buyers: Buyers have moderate bargaining power. The availability of alternative pain relief options provides buyers with choices. However, brand loyalty and medical recommendations influence purchase decisions.
Bargaining power of suppliers: Suppliers have low to moderate bargaining power due to the availability of substitute raw materials and components. However, manufacturers rely on technology and IP from a few innovator companies.
Threat of new substitutes: The threat of substitutes is moderate. Alternative pain management options like pain relief medications pose a threat. However, focused treatment for menstrual cramps has few close substitutes.
Competitive rivalry: The competitive rivalry in the menstrual cramps treatment market is high due to the presence of prominent manufacturers. Companies compete on the basis of product features, price, marketing initiatives and geographic reach.
Key Takeaways
The Global Menstrual Cramps Treatment Market Demand is expected to witness high growth, exhibiting CAGR of 4.4% over the forecast period, due to increasing patient awareness and rising healthcare expenditure.
Regional analysis
North America dominates the menstrual cramps treatment market and is expected to continue its dominance over the forecast period. The increasing prevalence of gynecological disorders and growing awareness about therapeutics are expected to drive growth. Asia Pacific is anticipated to exhibit the fastest growth rate owing to rising healthcare infrastructure and surging disposable income in emerging economies.
Key players
Key players operating in the menstrual cramps treatment market are Stryker Corporation, SATELEC (Actongroup),Surgiform Innovative Surgical Products, Allergan (Abbvie) Luminera, Implantech, Koken, ANTHONY PRODUCTS INC., NOUVAG, Sihuan Pharmaceutical Holdings Group Ltd., and Other prominent players. Stryker Corporation and Allergan (Abbvie) are market leaders due to their strong geographical presence and extensive product portfolios.
